A new systematic review and meta-analysis conducted by supplement manufacturer Balchem concludes ferrous bisglycinate supplementation in pregnant women results in improved haemoglobin status and a 64% lower rate of side effects compared to other iron...
Hofseth BioCare (HBC) has successfully achieved New Dietary Ingredient (NDI) status from the US Food and Drug Administration for its ProGo bioactive peptides, having already achieved this for its CalGo and OmeGo ingredients.
Supplementation with a heat-killed bacterium may significantly increase iron status for young women, says new study from Japan that creates novel opportunities to address a leading global nutrient deficiency.
Supplementation with Lactiplantibacillus plantarum 299v may improve iron levels in healthy pregnant women and help to prevent iron deficiency for this important group, according to a new study from Sweden.
Norways’s Hofseth BioCare (HBC) has expanded its internation distribution deal for its salmon-derived portfolio of ingredients with IMCD, headquartered in the Netherlands.
